-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Protagonist Therapeutics, Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2021 to Q2 2024.
- Protagonist Therapeutics, Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 61.3M shares, a 7.98% increase year-over-year.
- Protagonist Therapeutics, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 56.8M shares, a 15.7% increase from 2022.
- Protagonist Therapeutics, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 49M shares, a 5.87% increase from 2021.
- Protagonist Therapeutics, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 46.3M shares, a 34.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)